It was recently suggested that higher plasma levels of IL-1α and TGF-β and lower levels of IFN-β could point to a greater risk of changes similar to those observed in pulmonary fibrosis in patients after COVID-1917. Here, IFNB1 is linked to pulmonary fibrosis.